TCORS: Center for the Assessment of Tobacco Regulations (CAsToR)

News

In the news: “Young People’s Nicotine Habits Are Changing - Here’s Why It Matters” in Newsweek">In the news: “Young People’s Nicotine Habits Are Changing - Here’s Why It Matters” in Newsweek">

Selected news

In the news: “Young People’s Nicotine Habits Are Changing - Here’s Why It Matters” in Newsweek
Kenneth Cummings, PhD, MPH
Kenneth Cummings, PhD, MPH
POSTED: Tue Aug 04, 2026
Dr. Mike Cummings discusses in Newsweek results from a recent paper in collaboration with CAsToR investigators.

Lead author K. Michael Cummings told Newsweek that their study reflects “some positive trends in reduced use of combustible tobacco use,” particularly among younger adults, and that “we should be looking at substantially fewer smoking-related cancers several decades from now. On a population-wide basis, the overall pattern of tobacco use is very good,” he said.
 
Read this article in Newsweek
In the news: “Flavored vapes led to a major shake‑up at the FDA” in the Conversation
Jamie Hartmann-Boyce, DPhil, Holly Jarman, PhD and Claire Ma, PhD
Jamie Hartmann-Boyce, DPhil, Holly Jarman, PhD and Claire Ma, PhD
POSTED: Thu May 21, 2026
“Researchers regularly assess the scientific evidence on whether e-cigarettes can help people stop smoking. Regularly updated evidence across more than a hundred studies continues to show that nicotine vapes can help people who use cigarettes to quit smoking.”
“Researchers don’t yet know whether or how adding flavors to vapes might affect smoking and vaping. While fruity and sweet flavors can be appealing to people who smoke, tobacco and menthol flavors are sometimes more popular among older people who have a history of smoking tobacco.”
 
Read this article in the Conversation
CAsToR e-Announcements (April 2026)
TAGS: #Newsletter
POSTED: Wed Apr 01, 2026
A bi-monthly e-newsletter of CAsToR highlights, events and more. Headlines: The Center for Rapid Surveillance of Tobacco (CRST) in collaboration with CAsToR published a data brief on the 2025 NYTS data. • RFA for scholarships: Summer Course on Tobacco Simulation Modeling • Workshops: “Forecasting the Impact of a U.S. Nicotine Reduction Standard on People with Disabilities” with Dana Rubenstein, MD, MHS and “Crafting Public Comments for Proposed Tobacco & Nicotine Rules” with Dr. Holly Jarman  
Read the CAsToR e-Announcements (April 2026)
CAsToR e-Announcements (January 2026)
TAGS: #Newsletter
POSTED: Thu Jan 29, 2026
A bi-monthly e-newsletter of CAsToR highlights, events and more. Headlines: New publication by Clinton Durney and CAsToR colleagues published in Tobacco Control: “Recent trends in sales of electronic nicotine devices and oral nicotine pouches by flavour.” • Upcoming Webinar: “Working with state & local tobacco legislative data: A primer” • Featured Junior Investigator: Reginald Hebert, PhD (Yale University)  
Read the CAsToR e-Announcements (January 2026)
CAsToR e-Announcements (November 2025)
TAGS: #Newsletter
POSTED: Fri Nov 14, 2025
A bi-monthly e-newsletter of CAsToR highlights, events and more. Headlines: CAsToR Investigators, Nargiz Travis and Dr. Jamie Hartmann-Boyce interviewed with the Guardian • CAsToR Investigator Dr. Luz Sanchez Romero presented a population simulation model for tobacco control • Five Junior Investigators funded for the 2025-2026 funding period, totaling $140,000.  
Read the CAsToR e-Announcements (November 2025)
In the news: “Experts concerned over health effects of high-dose nicotine pouches as sales soar in UK” in the Guardian
Nargiz Travis, MScPH and Jamie Hartmann-Boyce, DPhil
Nargiz Travis, MScPH and Jamie Hartmann-Boyce, DPhil
POSTED: Wed Nov 12, 2025
“Even more concerning is that in addition to the total nicotine content being high, they have a very high proportion of freebase nicotine, which facilitates faster delivery into the bloodstream. This makes them even more effective in delivering higher levels of nicotine compared to cigarettes.” — Nargiz Travis, MScPH (CAsToR Project Director, Georgetown University)
“A lot of the challenge in regulating in this space is recognising you have a reduced-risk product, but not a risk-free product. So how do we make sure it’s helping the people it can help, and isn’t harming the people who wouldn’t have otherwise used tobacco or nicotine?” — Jamie Hartmann-Boyce, DPhil (Assistant Professor, University of Massachusetts - Amherst and Co-Lead, CAsToR Policy Analysis and Dissemination (PAD) Core)
 
Read this article in the Guardian